COMET-AOA: Pilot Study Evaluating the Elasticity and Shear Wave Modulus (Stiffness) of the Median Nerve in Patients With Mild to Moderate Idiopathic Carpal Tunnel Syndrome Receiving OMT and Conservative Therapy

Sponsor
Kettering Health Network (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT06150443
Collaborator
American Osteopathic Association (Other)
36
3
18

Study Details

Study Description

Brief Summary

To evaluate and quantify changes in the elasticity and shear wave modulus (stiffness) of the median nerve in patients diagnosed with mild to moderate carpal tunnel syndrome following osteopathic manipulative therapy.

Condition or Disease Intervention/Treatment Phase
  • Other: Osteopathic manipulative treatment (OMT)
  • Other: Conservative treatment
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
36 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Pilot Study Evaluating the Elasticity and Shear Wave Modulus (Stiffness) of the Median Nerve in Patients With Mild to Moderate Idiopathic Carpal Tunnel Syndrome Receiving OMT and Conservative Therapy
Anticipated Study Start Date :
Mar 1, 2024
Anticipated Primary Completion Date :
Mar 1, 2025
Anticipated Study Completion Date :
Sep 1, 2025

Arms and Interventions

Arm Intervention/Treatment
Experimental: Group 1 - OMT Only

Osteopathic manipulative treatment will include the interosseous membrane technique, the flexor retinaculum soft tissue technique, and the radiocarpal somatic dysfunction technique. The cervical spine will also be treated, with particular attention to the C5-7 levels, all the way to the wrist and hand as the physician sees fit based on the findings of the osteopathic structural exam.

Other: Osteopathic manipulative treatment (OMT)
Two osteopathic primary care physicians will performing osteopathic manipulative techniques with a minimum of three direct techniques focused on carpal tunnel. These techniques will include the interosseous membrane technique, the flexor retinaculum soft tissue technique, and the radiocarpal somatic dysfunction technique. They will also evaluate and treat the cervical spine, with particular attention to the C5-7 levels, all the way to the wrist and hand as they see fit based on the findings of their osteopathic structural exam.

Active Comparator: Group 2 - OMT + Conservative Treatment

Will receive Osteopathic manipulative treatment in addition to conservative treatment. Conservative therapy will be defined as including the use of splints, NSAIDs, opioids, and therapeutic injection of the carpal tunnel with steroids. Physical and Occupational therapy will be excluded from the conservative therapy regimen. Osteopathic manipulative treatment will include the interosseous membrane technique, the flexor retinaculum soft tissue technique, and the radiocarpal somatic dysfunction technique. The cervical spine will also be treated, with particular attention to the C5-7 levels, all the way to the wrist and hand as the physician sees fit based on the findings of the osteopathic structural exam.

Other: Osteopathic manipulative treatment (OMT)
Two osteopathic primary care physicians will performing osteopathic manipulative techniques with a minimum of three direct techniques focused on carpal tunnel. These techniques will include the interosseous membrane technique, the flexor retinaculum soft tissue technique, and the radiocarpal somatic dysfunction technique. They will also evaluate and treat the cervical spine, with particular attention to the C5-7 levels, all the way to the wrist and hand as they see fit based on the findings of their osteopathic structural exam.

Other: Conservative treatment
Conservative therapy will be defined as including the use of splints, NSAIDs, opioids, and therapeutic injection of the carpal tunnel with steroids. Physical therapy will be excluded from the conservative therapy regimen.

Active Comparator: Group 3 - Conservative Treatment Only

Conservative therapy will be defined as including the use of splints, NSAIDs, opioids, and therapeutic injection of the carpal tunnel with steroids. Physical and Occupational therapy will be excluded from the conservative therapy regimen.

Other: Conservative treatment
Conservative therapy will be defined as including the use of splints, NSAIDs, opioids, and therapeutic injection of the carpal tunnel with steroids. Physical therapy will be excluded from the conservative therapy regimen.

Outcome Measures

Primary Outcome Measures

  1. Elasticity of median nerve at the carpal tunnel inlet [baseline, post 2-week treatment, post 4-week treatment, post 6-week treatment]

    Measured by shear wave elastography.

  2. Cross-sectional area of median nerve in 3 locations [baseline, post 2-week treatment, post 4-week treatment, post 6-week treatment]

    Measured by real-time grayscale ultrasound

  3. Quick DASH Patient Survey Score [Completed at treatment visits (initial, 2 weeks, 4 weeks, and 6 weeks)]

    This questionnaire asks the patient about their symptoms as well as their ability to perform certain activities. The QuickDASH, published in 2005 in the Journal of Bone and Joint Surgery, is a subset of 11 items from the 30-item DASH and is a self-reported questionnaire in which the response options are presented as 5-point Likert scales. At least 10 of the 11 items must be completed for a score to be calculated and the scores range from 0 (no disability) to 100 (most severe disability). This score was designed be useful in patients with any musculoskeletal disorder of the upper limb.

  4. CTS-6 Evaluation Tool Score [Completed at treatment visits (initial, 2 weeks, 4 weeks, and 6 weeks)]

    The Value Added by Electrodiagnostic Testing in the Diagnosis of Carpal Tunnel Syndrome completed by the clinician. A score >12 = 0.80 probability of Carpal Tunnel Syndrome and a score >5 = 0.25 probability of Carpal Tunnel Syndrome.

  5. Elasticity of the transverse carpal ligament [baseline, post 2-week treatment, post 4-week treatment, post 6-week treatment]

    Measured by shear wave elastography.

  6. Elasticity of the subsynovial connective tissue in the carpal tunnel [baseline, post 2-week treatment, post 4-week treatment, post 6-week treatment]

    Measured by shear wave elastography.

Secondary Outcome Measures

  1. Motor Distal Latency [Baseline and at 8 weeks (end of study)]

    Time it takes for an impulse to traverse the segment nearest the muscle.

  2. Sensory Distal Latency [Baseline and at 8 weeks (end of study)]

    Time it takes for an impulse to traverse the segment nearest the muscle.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 65 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Diagnosis of unilateral or bilateral mild to moderate carpal tunnel syndrome, based on recent EMG findings
Exclusion Criteria:
  • History of undergoing recent physical therapy for treatment of carpal tunnel syndrome

  • History of wrist trauma or surgery

  • Hypothyroidism

  • Severe CTS that has progressed to muscle atrophy

  • Systemic disease or condition including but not limited to diabetes mellitus, thyroid disorders, rheumatoid disorders, Paget's bone disease, gout, myxedema, multiple myeloma, acromegaly, hepatic disease, dialysis patients, or other diseases or conditions in which peripheral neuropathies are common.

  • Secondary cause of CTS such as a ganglion cyst, mass, or an accessory muscle shown by US or MRI of the affected wrist.

  • Bifid median nerve as shown by US or MRI of the affected wrist

  • pregnant or recently postpartum

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Kettering Health Network
  • American Osteopathic Association

Investigators

  • Principal Investigator: Roland Gazaille, DO, Kettering Health

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Kettering Health Network
ClinicalTrials.gov Identifier:
NCT06150443
Other Study ID Numbers:
  • KHN-2023-130
First Posted:
Nov 29, 2023
Last Update Posted:
Nov 29, 2023
Last Verified:
Nov 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Nov 29, 2023